Alpha-V Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy

doi 10.21236/ada476052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy

Pharmaceutics
Pharmaceutical Science
2019English

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy

Cancer Research
Cancer ResearchOncology
2016English

Metronomic Chemotherapy in Metastatic Breast Cancer

Novel Research in Sciences
2019English

Sorafenib Enhances the in Vitro Anti-Endothelial Effects of Low Dose (Metronomic) Chemotherapy

Oncology Reports
MedicineCancer ResearchOncology
2010English

Αvβ3 Integrin-Targeted Micellar Mertansine Prodrug Effectively Inhibits Triple-Negative Breast Cancer in Vivo

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2017English

Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

PET Imaging of Angiogenesis After Myocardial Infarction/Reperfusion Using a One-Step Labeled Integrin-Targeted Tracer 18f-AlF-Nota-Prgd2

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2012English

Antiintegrin Alpha v Beta 3 Blocks Human Breast Cancer Growth and Angiogenesis in Human Skin.

Journal of Clinical Investigation
Medicine
1995English

Quality of Life in Patients With Metastatic Breast Cancer Treated With Metronomic Chemotherapy

Future Oncology
MedicineCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy